Filter Results:
(5,344)
Show Results For
- All HBS Web
(5,344)
- People (2)
- News (1,575)
- Research (3,180)
- Events (17)
- Multimedia (123)
- Faculty Publications (1,856)
Show Results For
- All HBS Web
(5,344)
- People (2)
- News (1,575)
- Research (3,180)
- Events (17)
- Multimedia (123)
- Faculty Publications (1,856)
- 27 Apr 2020
- News
Key tools for remote working
- 26 Jul 2019
- News
10 Common-Sense Rules for a Customer-Centric Business Culture
- 09 Apr 2012
- News
HBS Prof. Publishes Book on Start-Ups
- August 1988 (Revised July 1996)
- Case
Colt Industries
Colt Industries is a conglomerate that is considering undertaking a leveraged recapitalization. The deal would involve a large one-time dividend to stockholders, which would be financed by over $1 billion in new debt. Unlike in an leveraged buyout, however, public... View Details
Keywords: Business Conglomerates; Equity; Economic Growth; Ownership Stake; Stocks; Borrowing and Debt; Employee Stock Ownership Plan; Financial Strategy
Stein, Jeremy C. "Colt Industries." Harvard Business School Case 289-012, August 1988. (Revised July 1996.)
- May–June 2021
- Article
Eliminate Strategic Overload
As companies respond to intensifying competitive pressures and challenges, they ask more and more of their employees. But organizations often have very little to show for the efforts of their talented and engaged workers. By selecting fewer initiatives with greater... View Details
Keywords: Strategic Initiatives; Value-based Strategy; Organizational Effectiveness; Strategy; Value Creation
Oberholzer-Gee, Felix. "Eliminate Strategic Overload." Harvard Business Review 99, no. 3 (May–June 2021): 88–97.
- 23 Mar 2021
- Cold Call Podcast
Managing Future Growth at an Innovative Workforce Education Startup
Keywords: Re: William A. Sahlman
- 26 Mar 2018
- Working Paper Summaries
The Impact of CEOs in the Public Sector: Evidence from the English NHS
- November 2013 (Revised September 2015)
- Supplement
GlaxoSmithKline in China (B)
By: John A. Quelch and Margaret L. Rodriguez
In 2013, Chinese investigators detained four GSK employees for allegedly bribing health care staff to sell GSK pharmaceuticals. A month later, GSK's Asia Pacific regional president, Abbas Hussain, said the company would help identify corrupt practices. Two days later,... View Details
Keywords: Public Health; Pharmaceuticals; China; Bribery; CSR; Hong Bao; Health Care; Drug; GlaxoSmithKline; GSK; Witty; Government; Marketing; Health; Health Care and Treatment; Corporate Social Responsibility and Impact; Corporate Strategy; Corporate Governance; Business and Government Relations; Ethics; Pharmaceutical Industry; China; United Kingdom; United States
Quelch, John A., and Margaret L. Rodriguez. "GlaxoSmithKline in China (B)." Harvard Business School Supplement 514-050, November 2013. (Revised September 2015.)
- 13 Nov 2014
- News
Turning Missions into Movements
- 27 Mar 2017
- News
How Companies Can Benefit More From Their Corporate Giving
- 04 Feb 2020
- Video
Dr. Elizabeth Mary Okelo
Mary Okelo, who pursued a successful career as an executive of British-owned Barclays Bank In Kenya before founding the only women’s bank in Africa and the Makini schools system, explains how she was regarded... View Details
- 23 May 2000
- Research & Ideas
Minding the Muse: The Impact of Downsizing on Corporate Creativity
found that the creative environment, and creativity itself, remained depressed four months after the layoffs had been completed. To corroborate this conclusion, Amabile and Conti compared how many invention disclosures had been filed by View Details
Keywords: by Peter K. Jacobs
- Research Summary
Personal Development and Interpersonal Feedback
Enabling individual development and learning are key to enabling organizational success as well as employee satisfaction and engagement. Many organizational approaches to employee development visualize feedback processes as mechanisms for illuminating individual... View Details
- March 2022 (Revised January 2023)
- Case
Innovation at Moog Inc.
By: Brian J. Hall, Ashley V. Whillans, Davis Heniford, Dominika Randle and Caroline Witten
This case focuses on the challenges of incentivizing innovation within Moog, an engineering company based in New York state that designs and builds guidance systems for space, air, and land-based travel. The case enables students to grapple with the challenges of using... View Details
Keywords: Innovation; Innovation Lab; Innovation Management; Motivation; Incentives; Culture; Compensation; Compensation And Benefits; Scalability; Business Growth and Maturation; Collaborative Innovation and Invention; Independent Innovation and Invention; Innovation and Management; Innovation Leadership; Innovation Strategy; Organizational Culture; Performance Consistency; Performance Effectiveness; Performance Efficiency; Performance Productivity; Performance Evaluation; Creativity; Motivation and Incentives; Aerospace Industry; Transportation Industry; United States
Hall, Brian J., Ashley V. Whillans, Davis Heniford, Dominika Randle, and Caroline Witten. "Innovation at Moog Inc." Harvard Business School Case 922-040, March 2022. (Revised January 2023.)
The Transparency Trap
To get people to be more creative and productive, managers increase transparency with open workspaces and access to real-time data. But my research shows that less-transparent work environments can actually yield more-transparent employees who solve problems more... View Details
- 15 Jun 2016
- Working Paper Summaries
Slack Time and Innovation
- January 2021
- Supplement
Takeda Pharmaceutical Company Limited (B)
By: David J. Collis, Nobuo Sato and Akiko Kanno
This case is a follow up to HBS Case No. 721-373, Takeda Pharmaceutical Company Limited (A). Following the events of the previous case, Takeda reached an agreement to acquire Ireland-based Shire Plc. The case follows some of the achievements and challenges Takeda and... View Details
Keywords: Pharmaceutical Companies; Pharmaceuticals; M＆A; Mergers ＆ Acquisitions; Biotech; Biotechnology; R＆D; Talent Management; Mergers and Acquisitions; Globalization; Global Strategy; Talent and Talent Management; Strategy; Biotechnology Industry; Pharmaceutical Industry; Japan; Asia
Collis, David J., Nobuo Sato, and Akiko Kanno. "Takeda Pharmaceutical Company Limited (B)." Harvard Business School Supplement 721-374, January 2021.
- August 2016
- Supplement
CEO Succession at Cisco (B): Announcement Strategy
By: Boris Groysberg, J. Yo-Jud Cheng and Annelena Lobb
Supplements the (A) case (417-031).
This case supplement describes Cisco’s communications strategy around the CEO announcement, which focused on controlling the narrative and avoiding leaks. The strategy included both internal and external processes aimed at... View Details
Groysberg, Boris, J. Yo-Jud Cheng, and Annelena Lobb. "CEO Succession at Cisco (B): Announcement Strategy." Harvard Business School Supplement 417-032, August 2016.
- 17 Jun 2020
- News